Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

217.11
BATS BZX Real-Time Price
As of 11:45am ET
 -1.00 / -0.46%
Today’s Change
212.67
Today|||52-Week Range
340.34
-30.52%
Year-to-Date
Pfizer's (PFE) Stock Gains in Pre-Market on Q1 Earnings Beat
9:53am / Zacks.com
Deals may be scuttled but nothing can prevent the talent from migrating
Apr 11 / FT.com
Stock Market News for May 02, 2016
May 02 / Zacks.com
Local politics can turn deal heroes to zeros
Apr 11 / FT.com
Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?
May 02 / TheStreet.com
M&A crackdown puts bond investors on edge
Apr 11 / FT.com
7 Things on Investors' Minds Heading Into Pfizer's Q1 Report Tomorrow
May 02 / MotleyFool.com
M&A splurge comes home to roost
Apr 08 / FT.com
3 Big Merger Deals That Regulators Challenged and What It Means
Apr 30 / TheStreet.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
Better Buy: The Coca-Cola Co vs. PepsiCo, Inc.
Apr 29 / MotleyFool.com
Pfizer chief's long quest for tax inversion ends in failure
Apr 06 / FT.com
Jerome Dodson Sells Stake in Citrix Systems in st Quarter
Apr 28 / GuruFocus News
M&A failures: deep breaths
Apr 06 / FT.com
Even the Fed Can't Make Stocks Budge
Apr 28 / TheStreet.com
US Treasury shatters Pfizer chief Ian Read's merger dreams
Apr 06 / FT.com
Pfizer (PFE) to Report Q1 Earnings: Will the Stock Surprise?
Apr 28 / Zacks.com
Pfizer merger collapse is serious failure of management
Apr 06 / FT.com
Daniel Loeb warns of hedge fund 'killing field'
Apr 27 / FT.com
Pfizer: plan C
Apr 06 / FT.com
Tax Inversions: Explaining What They Are, How We Got Here and What's Next
Apr 26 / TheStreet.com
Pfizer-Allergan merger scrapped after Obama cracks down on tax breaks
Apr 06 / CNNMoney.com
Will the Next President Be as Tough on Mergers and Acquisitions as Obama?
Apr 26 / TheStreet.com
Stocks: 5 things to know before the open
Apr 06 / CNNMoney.com
Treasury Department Was 'Targeting' Pfizer-Allergan Deal
Apr 26 / TheStreet.com
Pfizer and Allergan abandon $160bn deal after US tax crackdown
Apr 06 / FT.com
With New Treasury Department Rules, Is This the End of Tax Inversion Deals?
Apr 26 / TheStreet.com
US tax crackdown provokes foreign fury
Apr 05 / FT.com
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One
Apr 26 / TheStreet.com
Hedge funds knocked by Allergan's fall
Apr 05 / FT.com
Celgene (CELG) Q1 Earnings: What's in Store for the Stock?
Apr 25 / Zacks.com
US crackdown on inversions came 'out of left field'
Apr 05 / FT.com
The week: April 25
Apr 24 / FT.com
Washington slams shut Pfizer's tax loophole
Apr 05 / FT.com
3 Stocks We're Ready to Buy Again
Apr 22 / MotleyFool.com
Treasury's shot at tax inversions will cause collateral damage
Apr 05 / FT.com
3 Value Stocks Near 52-Week Lows Worth Buying
Apr 20 / MotleyFool.com
Tax inversions: bloody nightmare
Apr 05 / FT.com
What's Behind Synergy Pharmaceuticals' Soaring Shares Today
Apr 19 / MotleyFool.com
New U.S. tax rules throw $160 billion merger into doubt
Apr 05 / CNNMoney.com
3 Biggest Challenges Facing Lannett Company Inc. Stock
Apr 19 / MotleyFool.com
Tax inversions: what the new rules mean
Apr 05 / FT.com
Paulson's funds plunge nearly $2bn on Allergan and Valeant bets
Apr 19 / FT.com
Stocks: 5 things to know before the open
Apr 05 / CNNMoney.com
UK companies more likely to hire outside CEOs
Apr 18 / FT.com
Allergan plunges on inversion curbs, the transatlantic tax tussle and a disease that ...
Apr 05 / FT.com
It's time for an outright ban on mega-transactions
Apr 13 / FT.com
Allergan plunges 22% on new tax inversion curbs
Apr 04 / FT.com
Companies cannot escape nationalities and borders
Apr 13 / FT.com